Teva Pharmaceutical Industries Limited (TEVA) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 07:00 ET. Consensus EPS estimate is $0.72.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-29 | FY2026 Q1 | $0.50 | $0.53 | +6.0% | $3.98B |
| 2026-02-03 | FY2025 Q4 | $0.65 | $0.96 | +47.7% | $4.71B |
| 2025-11-05 | FY2025 Q3 | $0.68 | $0.75 | +10.3% | $4.48B |
| 2025-07-30 | FY2025 Q2 | $0.63 | $0.66 | +4.8% | $4.18B |
| 2025-05-07 | FY2025 Q1 | $0.47 | $0.52 | +10.6% | $3.89B |
| 2025-02-05 | FY2024 Q4 | $0.69 | $0.71 | +2.9% | $4.23B |
| 2024-11-06 | FY2024 Q3 | $0.65 | $0.69 | +6.2% | $4.33B |
| 2024-07-31 | FY2024 Q2 | $0.57 | $0.61 | +7.0% | $4.16B |
TEVA has beaten consensus EPS in 8 of its last 8 reported quarters.
See TEVA on the live calendar →